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Abstract
Background: Breast cancer can present as non-mass lesions (NMLs) on ultrasound. However, knowledge of and
understanding about NMLs are scarce.
Purpose: To retrospectively investigate the final outcomes of sonographic breast NMLs and determine the clinical and
radiologic variables associated with malignancy
Material and Methods: In our radiologic database of breast ultrasound examinations between 2011 and 2014, we
found 119 women with 121 NMLs with available histopathologic or sonographic follow-up (over 2 years) data. We
collected the clinical variables (patient’s age, symptoms, and mammographic density) and histopathologic data as well as
radiologic variables (mammographic and ultrasound findings) after retrospective review by two radiologists, the authors
of the current paper, in consensus. We classified the ultrasound findings according to distribution (focal, linear or
segmental, and regional) and associated features (calcification, architectural distortion, and ductal changes) and analyzed
the associations between variables and malignancy using the t test and 2 test.
Results: Of the 121 NMLs, 88 (72.7%) were benign and 33 (27.3%) were malignant. Ductal carcinoma in situ (DCIS)
(17/33, 51.5%) and invasive ductal cancer with or without DCIS (13/33, 39.4%) comprised the main malignancies, and
malignancy was significantly associated with palpability (P¼ 0.000). Mammographic findings and sonographic distribution
and associated features were significantly different between benign and malignant lesions (P¼ 0.000, P¼ 0.004, and
P¼ 0.001, respectively). Malignant lesions showed more frequent calcifications combined with asymmetry (P¼ 0.000)
on mammography and linear-segmental distributions (P¼ 0.001) and associated calcifications (P¼ 0.019) or architectural
distortions (P¼ 0.015) on ultrasound.
Conclusion: Breast NMLs on ultrasound showed high risk of malignancy. Symptoms and mammographic and ultrasound
findings can be possible predictors of malignancy in NMLs.
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Introduction
Breast ultrasound (US) has been well established as a
valuable modality in differentiating benign from malig-
nant lesions in many well-designed reader studies (1,2).
However, the lesions included in these studies were
nearly all breast masses, and there has been no interest
in non-mass breast lesions in breast US research. With
two-dimensional breast US, a mass can be defined as a
space-occupying lesion seen in two different planes,
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but if it cannot be characterized as a mass because of
lack of a conspicuous margin or shape, it should be
reported as a non-mass lesion (NML). It has been
described as synonymous terms such as non-mass like
lesion, non-mass lesion, non-mass image-forming
lesion, ductal changes, duct-like structures, and focal
shadowing (3–7). The multiplicity of names reflects an
underlying uncertainty as to the true nature of sono-
graphic NMLs. Uematsu et al. (3) first introduced non-
mass-like lesions detected on breast US in their review
article and classified them as ductal hypoechoic areas
and non-ductal hypoechoic areas. In addition, accord-
ing to a few prior articles (4–7), the incidence of such
lesions was 5.3% on screening or diagnostic breast US
examinations, and moreover, these followed a wide
pathologic spectrum from benign lesions such as fibro-
cystic changes or stromal fibrosis to malignancy ones
such as ductal carcinoma in situ (DCIS) or invasive
cancer that showed high association with malignancy
(16–35%). However, knowledge of and understanding
about NMLs are still scarce, and there have been few
published reports regarding NMLs (3–7). Therefore,
our study aimed to investigate the final outcomes of
non-mass breast lesions detected on US and determine
their clinical and radiologic variables to differentiate
between benign and malignant lesions.
Material and Methods
The institutional review board approved this study, and
informed consent was waived.
Study cohort
Through our radiologic records of all breast US exam-
inations from January 2011 to December 2014, we iden-
tified 125 consecutive patients with 129 lesions classified
as breast NMLs. Eight (6.2%) of the 129 lesions were
excluded because histopathologic results or sonographic
follow-up over 2 years were not available. The remaining
121 NMLs in 119 patients comprised the dataset of our
study (Fig. 1). Two patients had two lesions and two had
a personal history of breast cancer.
The mean age of the patients was 46.5 years (age
range, 21–69 years). Thirty- nine (32.2%) of the total
of 121 NMLs were associated with symptoms, includ-
ing palpability (n ¼ 28) and nipple discharge (n ¼ 11).
Eighty-two (67.8%) lesions were detected in asymptom-
atic patients. The mean size of the lesions was 25.3mm
(range, 6–63mm).
Mammography
Mammography was available for 95 (78.5%) patients
with 97 lesions during the US examinations. Four
mammographic studies in four patients had been per-
formed in outside hospitals. Omission of mammog-
raphy in 24 (21.5%) patients was due to their youth
(aged less than 40 years). The mammographic tissue
density of each patient was collected from the reported
data, and the authors of the study, two radiologists
with 10–11 years of experience in breast imaging,
reviewed the mammographic findings for the areas
that corresponded with the NMLs until consensus.
We categorized breast tissue density as almost fatty,
scattered fibroglandular, heterogeneously dense, or
extremely dense according to the Breast Imaging
Reporting and Data System (BI-RADS) (8), and cate-
gorized the findings as negative, mass, calcifications
(Fig. 2), asymmetry (Fig. 3), or architectural distortion.
Ultrasound
All breast US examinations were hand-held sonography
scans and were performed by one of three radiologists
who had practiced as faculty in an academic breast ima-
ging section over 5–10 years, and all included bilateral
whole breasts and axillae with the patient in the supine
position with the ipsilateral arm raised. Aixploler
(Supersonic Imagine, Aix-en-provence, France), IU 22
(Philips, Medical Systems, Bothell, WA, USA) or HDI
5000 (Philips Advanced Technology Laboratories,
Bothell, WA, USA) US systems were used with an 8–
13MHz linear array transducer. The radiologist who
performed the US was informed of all clinical and mam-
mographic findings. All lesions were assessed in both
radial and anti-radial scanning planes. With real-time
scanning, if the lesion was visible on two orthogonal
planes but could not be characterized as a distinct
mass because of lack of a conspicuous margin or
shape, we considered it an NML.
For each NML, we retrospectively reviewed its dis-
tribution and associated sonographic features. Before
the study, we had discussed the concise definitions of
the descriptors and come to consensus about them
using detailed documents. For distribution, we classi-
fied the NMLs as focal, linear-segmental, or regional
pattern. A focal distribution was defined as a small and
Fig. 1. Flowchart of inclusion criteria.
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confined area. A linear-segmental distribution (Fig. 2)
was defined as a longitudinal or a triangular area that
arrayed in a line or along the branches involving one or
more ducts. A regional distribution (Fig. 3) was defined
as a large geographic area of tissue that did not con-
form to a ductal or segmental distribution. For asso-
ciated features, we sorted the NMLs into the categories
of calcifications, architectural distortion, or abnormal
Fig. 2. A 45-year-old woman with biopsy proven DCIS. Mammography: ((a) craniocaudal view; (b) mediolateraloblique view) shows
segmentally distributed pleomorphic microcalcifications (arrows) at the right lower medial breast. Sonography scan (c) shows linear or
segmentally distributed NML with duct ectasia and calcifications (circle) correlating with the mammographic abnormality in the right
breast.
Axial first contrast-enhanced subtraction MR image (d) shows homogeneous, segmental non-mass enhancement (arrows) in the
corresponding area in the right breast. Sonographically guided core biopsy was performed and the specimen radiograph. Core biopsy
and surgery confirmed the lesion to be DCIS (high grade, comedo type, without microinvasion).
Fig. 3. A 69-year-old woman with DCIS. Mammography ((a) craniocaudal view; (b) mediolateraloblique view) shows a focal asym-
metry (arrows) at the palpable region (BB marker) in the right breast.
Sonography scans ((c) anti-radial; (d) radial) show a regionally distributed NML (arrows) at the corresponding area in the right breast.
Sonographically guided core biopsy and surgery confirmed the lesion as DCIS (intermediate grade, non-comedo type, without
microinvasion).
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ductal changes. We recognized associated calcifications
as echogenic foci or echogenic flecks with or without
shadowing that were embedded in the NML, near the
outside of the NML, or in a duct or ducts. We con-
sidered architectural distortion to be compression of
the tissue around the NML, obliteration of the tissue
planes by an infiltrating lesion, straightening or
thickening of Cooper ligaments, aberrations of ductal
patterns, or an echogenic rim. Abnormal ductal
changes meant the cystic or cylindrical dilatation of a
duct or ducts involving irregularities in caliber and/or
arborization, extension of ducts or the presence of an
intra-ductal mass, thrombus, or detritus.
Biopsy and surgery
US-guided biopsies were performed with high reso-
lution US units with an 8–13MHz linear array trans-
ducer using a freehand technique. Tissue specimens
were obtained with a 14-gauge automated needle
(Pro-Mag 2.2, Manan Medical Products, Northbrook,
IL, USA) and a 14-gauge Tru-Cut needle with a 22mm
throw (SACNTM Biopsy Needle, Medical Device
Technologies, Gainesville, FL, USA) or vacuum-
assisted needle (Mammotome; Ethicon Endo-Surgery,
Cincinnati, OH, USA) by one of the radiologists with
5–10 years of experience in breast imaging and biopsy.
US-guided 14-gauge core biopsy was performed for 101
lesions and US-guided vacuum-assisted needle core
biopsy was performed for eight lesions. Forty lesions
were surgically excised, and in cases of non-palpable
lesions, US-guided preoperative localization was done
with a 21-gauge Kopan needle.
Statistical analysis
We conducted the statistical analyses using Student’s t
test, 2 test, or Fisher’s exact test to evaluate whether
clinical (age, symptom, and mammographic density)
and radiologic (mammographic abnormality, US fea-
tures) variables were associated with malignancy. We
used the final histopathologic results as a standard to
assess malignancy and categorized the lesions as benign
or malignant lesions. High-risk lesions were considered
benign for statistical analysis. P value of <0.05 was
considered statistically significant. All statistical ana-
lyses were conducted using software (SPSS, version
22.0: SPSS Inc, Chicago, IL, USA).
Results
Final outcomes
Of the 121 lesions, we obtained tissue diagnoses for 115
(95%), and sonographic follow-up over 2 years was
performed for six (5%) lesions. For 40 lesions, includ-
ing 39 that were confirmed histopathologically by core
biopsy, surgery was performed within 0–5 months
because of the presence of malignancy (n¼ 33),
core biopsy results of imaging-histologic discordance
(n¼ 2), high-risk pathologic findings including atypical
ductal hyperplasia (n ¼ 2), atypical lobular hyperplasia
(n¼ 1), and pleomorphic lobular carcinoma in situ
(n¼ 1), or physician’s decision (n¼ 1).
The histopathologic findings of the 115 NMLs
revealed 33 malignancies in 33 patients (17, 51.5%,
DCIS; 8, 24.2%, invasive ductal cancer [IDC]; 5,
15.2%, minimal IDC with DCIS; 1, 3.0%, mixed IDC
and invasive lobular cancer [ILC]; 1, 3.0%, ILC; 1, 3.0%
intra-ductal papillary cancer) and 82 benign diseases in
81 patients (23, 28.0%, fibrocystic changes; 21, 25.6%
stromal fibrosis; 12, 14.6%, fibroadenomatoid hyperpla-
sia; 9, 11.0%, sclerosing adenosis; 4, 4.9%, lobular car-
cinoma in situ; 3, 3.7%, granulomatous mastitis; 3,
3.7%, intraductal papillomas; 2, 2.4%, abscesses; 2,
2.4%, chronic mastitis; 1, 1.2%, ductectasia; 1, 1.2%,
atypical ductal hyperplasia; 1, 1.2%, DM mastopathy;
1, 1.2%, lymphangioma). The sonographically followed
lesions (n¼ 6) were unchanged during the follow-up
period (mean, 33 11 months; range, 24–57 months),
and no malignancies developed. Thus, the malignancy
rate of the 121 NMLs was 27.3% (33/121).
Clinical variables
The clinical findings between the benign and malig-
nant NMLs are shown in Table 1. Patients with malig-
nant NMLs had more frequent symptoms compared
with those with benign NMLs (P¼ 0.000). Among the
88 benign lesions, 19 (21.6%) had associated symp-
toms. The most common symptom was nipple dis-
charge (11/88, 12.5%), followed by palpability (8/88,
9.1%) (Fig. 3). Whereas 20 (60.6%) of the 33 malig-
nant lesions had symptoms, palpability was the only
symptom. Palpability was more frequent in patients
with malignant NMLs than in those with benign
NMLs (P¼ 0.000). However, other clinical findings,
such as age and mammographic density, were not
significantly different between the benign and malig-
nant lesions.
Radiologic variables
Table 2 summarizes the radiologic findings between the
benign and malignant NMLs. Malignant NMLs were
more associated with mammographic abnormalities
than were benign NMLs (27/32, 84.4% versus 25/63,
39.7%, P¼ 0.000). Among the 32 malignant lesions, the
most common mammographic abnormalities were cal-
cification combined with asymmetry (12/32, 37.5%),
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followed by calcification (9/32, 28.1%) (Fig. 2).
Calcification combined with asymmetry was more fre-
quent in malignant than in benign lesions (P¼ 0.000),
but calcification alone showed no significant difference.
Four (30.8%) of 13 mammographic calcifications with
benign NMLs were classified into BI-RADS category
4A, and the remaining nine were in category 3.
Meanwhile, all 21 calcifications in malignant NMLs
were classified into BI-RADS categories 4 or 5.
The US examinations showed significant differences
in the distribution between the benign and malignant
lesions (P¼ 0.004). Fifteen (45.5%) of the 33 malignant
NMLs showed linear or segmental distributions (Fig.
2), followed by focal (11/33. 33.3%) and regional (7/33,
21.2%) (Fig. 3), whereas among the 88 benign lesions,
focal distribution was noted in 53 (60.2%), regional
distribution in 20 (22.7%), and linear or segmental dis-
tribution in 15 (17%). Linear or segmental distribution
Table 2. Radiological findings of benign and malignant non-mass breast lesions.
Radiological findings Benign Malignant P value Odds ratio (95% CI)
Mammographic abnormality* 63 32 0.000
Calcification 9 (14.3) 9 (28.1)
Asymmetry 8 (12.7) 5 (15.6)
Architectural distortion 4 (6.3) 1 (3.1)
Combined (calcification with asymmetry) 4 (6.3) 12 (37.5) 0.000 0.113 (0.033–0.390)
None 38 (60.3) 5 (15.6)
Ultrasound distribution 88 33 0.004
Focal 53 (60.2) 11 (33.3)
Linear or segmental 15 (17.0) 15 (45.5) 0.001 4.056 (1.679–9.799)
Regional 20 (22.7) 7 (21.2)
Ultrasound associated feature 88 33 0.001
Calcification 9 (10.2) 9 (27.3) 0.019 0.304 (0.108-0.852)
Architectural distortion 4 (4.5) 6 (18.2) 0.015 4.667 (1.225-17.776)
Ductectasia 6 (6.8) 4 (12.1)
Combined (calcification with ductectasia) 1 (1.1) 2 (6.1)
None 68 (77.3) 12 (36.4)
Unless otherwise indicated, data are numbers of patients and numbers in parentheses are percentages.
*
Mammography was available in 95 women with 63 benign lesions and 32 malignant lesions.
Table 1. Clinical findings of benign and malignant non-mass breast lesions.
Variable Benign (n¼ 88) Malignant (n¼ 33) P value Odds ratio (95% CI)
Patient age (years) 44.95 10.183* 49.21 7.833* 0.064
Symptom 88 33 0.000
Palpability 8 (9.1) 20 (60.6) 0.000 0.065 (0.024–0.178)
Nipple discharge 11(12.5) 0 (0)
None 69 (78.4) 13 (14.8)
Mammographic density§ 63 32 0.425
2 (scattered fibrograndular tissue) 3 (4.8) 1 (3.1)
3 (heterogeneously dense) 54 (85.7) 29 (90.6)
4 (extremely dense) 6 (9.5) 2 (6.3)
Unless otherwise indicated, data are numbers of patients and numbers in parentheses are percentages.
*
Data are mean values, with standard deviation.
§
Mammography was available in 95 women with 63 benign lesions and 32 malignant lesions.
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was more common in malignant than in benign lesions
(P¼ 0.001) (Fig. 2). US associated features were more
frequently seen in malignancy lesions (21/33, 63.6%
versus 20/88, 22.7%, P¼ 0.001). Among the associated
features, calcifications were the most commonly seen in
both benign and malignant lesions but showed a sig-
nificant difference between the two (9/88, 10.2% versus
9/33, 27.3%, P¼ 0.019) (Fig. 2). Architectural distor-
tion was also a more frequent associated feature in
malignant than in benign lesions on US (6/33, 18.2%
versus 4/88, 4.5%, P¼ 0.015).
Discussion
The histopathological results revealed in this study cor-
responded to those of previous articles (3–7) and many
of NMLs on breast US were identified as DCIS or
DCIS with minimal IDC (10.2–20.7%) or 24 (32%)
of 77 cases of DCIS were non-mass image forming
type (4–7). In other research on the sonographic fea-
tures of DCIS (9,10), 26 (11%) of 231 DCIS or seven
(19%) of 36 non-calcified DCIS showed as NMLs and
asymptomatic or low-grade DCIS was more associated
with NMLs than masses.
With regards to the US findings for the NMLs,
because there is no standardized method for analysis,
prior articles each used different methods for analysis
(3–6,11). In 2004, the Japanese Association of Breast
and Thyroid Sonology systemically organized and clas-
sified NMLs. Their criteria included abnormal ductal
changes, a multiple vesicular pattern, hypoechoic areas
in the breast tissue, and architectural distortion (11).
Morishma et al. categorized ultrasonic non-mass
image forming breast cancers into four types: a homo-
geneous pattern, a ductal pattern, a mottled pattern,
and a geographic pattern, and concluded that the geo-
graphic pattern often contained invasive components
(4). In recent study by Ko et al. (5), US features of
120 benign and 44 malignant NMLs were categorized
into four types according to orientation, calcification,
architectural distortion, and posterior acoustic shadow-
ing, which was useful for clarifying the indication for
biopsy of the NMLs. Meanwhile, Kim et al. (6) classi-
fied US features of 156 benign and 30 malignant NMLs
into according to type, distribution, color flow, and
positive calcifications. In their study, malignant lesions
more frequently had mottled and geographic patterns,
regional distribution, visible calcification, and a greater
amount of color Doppler signals than benign lesions
(6). As mentioned above, US feature description of
NMLs has not been standardized, and, moreover,
some of the previous US feature analyses were compli-
cated and irreproducible, resulting in inter-observer dis-
agreement. To overcome this limitation, this study had
two radiologists who simply analyzed US findings
to consensus. We classified the NMLs according to dis-
tribution and associated features. Linear or segmental
distribution (P¼ 0.001) and associated calcification
(P¼ 0.019) or architectural distortion (P ¼ 0.015)
were predictable for malignancy. Some of our results
correlated with those of the prior studies (3–6). For
instance, linear-segmental distribution might be similar
to the ductal hypoechoic area in the study by Uematzu
et al. (3) and the ductal NML pattern in the study of
Ko et al. (5). Both of these groups of authors defined a
ductal hypoechoic area or a ductal NML pattern as a
lesion with the parallel orientation of multiple duct-like
structures (3,5). The definition was similar to our cri-
teria for linear or segmental distribution. According to
both sets of authors, a ductal hypoechoic area was an
indication for biopsy and positive predictive value was
high when associated calcifications were present regard-
less of ductal or non-ductal patterns (5). Compared
with that linear or segmental non-mass enhancement
on magnetic resonance imaging (MRI) was more
likely to indicate malignancy, particularly DCIS (12),
it is convincing that linear-segmental distribution is
more associated with malignant NMLs on US. In our
33 malignant lesions, 15 (45.5%) had linear or segmen-
tal distribution and, among these, 10 (66.7%) were
DCIS (90%, 9/10) or DCIS with micro-invasive
ductal cancer (10%, 1/10). Further extended study
would be needed to compare the NML findings on
US with those on MRI, in order to verify the exact
feature.
US associated calcification was a predictive factor
for malignancy both in most prior studies and in this
one (4–6). Nine (10.2%) of 88 benign and nine (27.3%)
of 33 malignant lesions showed calcifications on US
with a statistically significant difference (P ¼ 0.019).
Calcifications have been poorly characterized with son-
ography, but those associated with malignant tumors
were more likely to be seen sonographically because
most malignant calcifications occurred within hypoe-
choic breast masses as opposed to within echogenic
breast parenchyma in previous studies (13–15), and
we also observed this with NMLs. Additionally, US
associated architectural distortion was also more fre-
quent in malignant (6/33, 18.2%) than benign (4/88,
4.5%) NMLs.
For the clinical findings, palpability predicted malig-
nancy with the frequency of 20 (60.6%) of 33 malignant
lesions and eight (9.1%) of 88 benign ones in our study.
Kim et al. also reported that palpability was signifi-
cantly associated with malignancy showing higher fre-
quency (50%) in 30 malignant lesions compared with
2.6% (4/156) in benign ones (6).
According to Ko et al. (5), asymmetry combined
with calcification had no statistical difference between
benign and malignancy lesions, and only the
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mammographic finding of suspected malignancy had a
higher probability of malignancy. However, in our
study, mammographic abnormality was one of the pre-
dictive variables for malignancy. Calcification com-
bined with asymmetry was significantly more visible
in malignant (37.5%, 12/32) than in benign (6.3%,
4/63) NMLs. Among our 27 cases with mammographic
findings that were suspicious for malignancy, there were
20 (62.5%) malignancies and seven (11.1%) benign
lesions. Four (30.8%) of the 13 benign NMLs and all
21 of the malignant NMLs were classified as BI-RADS
categories 4 or 5.
There were limitations to our study. First, inter-
observer variability and irreproducibility are well-
known limitations of sonography. To reduce these
limitations, two experienced breast imaging specialists
discussed the concise definitions of the descriptors and
reached consensus on them using detailed documents
during the retrospective analysis of the US findings.
However, there is a need for an exact and concrete def-
inition of NMLs and future extended studies including
inter-observer variability will allow for their uniform
standardization. Second, this study was performed at
a single site institution and included only a small
number of subjects. As a result, some variable sub-
groups were poorly populated. Additional research is
needed at multiple institutions with larger numbers of
subjects.
In conclusion, breast NMLs on US showed high risk
of malignancy and DCIS was the main malignant path-
ology. NMLs have to be managed according to the
clinical, mammographic, and US findings. Palpability,
mammographic calcifications combined with asym-
metry, US linear-segmental distribution, and US asso-
ciated calcifications or architectural distortion were
more common in malignant than in benign NMLs.
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